Clinical Trial

A Study（Phase I）of GS3-007a Dry Suspension in Healthy Chinese Adults

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 16, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This study consists of two parts: the first part is a single-dose escalating（SAD） and food effect （FE）study, and the second part is a multiple-dose (14-day) escalating(MAD) study. Both phases are designed as randomized, double-blind, dose-escalation, placebo-controlled clinical studies.
Trial Details
NCT Number NCT07473570
Lead Sponsor Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions Healthy Adults
Enrollment 32 participants
Start Date 2026-01-07
Primary Completion 2026-06 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-03-16